Sydney, New South Wales, Australia
The MIMS Group covers 18 Countries with 36 offices and approx 1,200 staff. As part of the Group’s Executive Team, my corporate roles across the Pacific region include; CEO and Executive Director for MIMS Australia and MIMS New Zealand (ANZ), Executive Vice President for MIMS Healthcare Data Pacific business, and CEO of eHealthWise Services. My responsibility is to drive; business strategy, P&L, growth and operations across these three Pacific businesses, working closely with overall Group CEO, Investment and Executive Teams in both Singapore and Tokyo (HQ). I led the acquisition of eHealthwise Services in January 2014 to SMS Co Limited, and further assisted our Tokyo HQ team with the October 2015 MIMS Group acquisition (a USD$250million JV between SMS and Mitsui). My current industry role is; National President of the MSIA (Medical Software Industry Association) of Australia. As President, my role is to balance the relationships between our CEO, Board, Governments, Industry Stakeholders and HealthTech Members to ensure we represent the interests of the Australian Medical Software Industry (which develops and supplies clinical, medical and digital health technology solutions to over 95% of healthcare professionals and the broader healthcare industry across Australia). The MIMS Group Shareholders, until Q4 2018, were; SMS Co Ltd ("SMS") and Mitsui & Co Ltd ("Mitsui") - listed on the Tokyo Stock Exchange (TYO Code: 2175 and 8031 respectively). SMS entities subsequently acquired Mitsui's shareholding in MIMS Group. SMS has a market cap of approx USD$2.8B and Mitsui & Co a market cap of approx USD$25B. Both companies own a range of Health and Life Science Assets, Technology Products and Services across; Hospitals, Clinics, Pharmacies, and Healthcare professionals. +25 years of diverse business management skills covering; Industry and Corporate C-Suite roles, Board Leadership, Management, Governance & IP Commercialization across Public and Private Companies. Bachelor of Commerce Degree (International Business, Technology platform delivery, Strategy/Marketing/Advertising/Brand Building) - strong APAC experience with interpersonnel skills covering multicultural strategic engagement.
As CEO, Director, and Executive Vice President of the MIMS Healthcare Data Pacific Business, I lead the MIMS Australia and New Zealand (ANZ) businesses with full responsibility to drive strategy, M&A, P&L and operations across APAC markets. MIMS is one of APAC's leading B2B Healthcare Data companies providing tailored subscription solutions to the wider healthcare market. With ~1,100 staff, we provide a range of health technology solutions covering; medicine reference data, critical decision support modules, news and education to +2.5m general practitioners, specialist doctors, pharmacists, and nurses from our 36 offices covering 18 countries. As a leading Subscriptions based business, we actively engage with Federal and State Health Departments, (Dept of Health, Dept of Human Services), TGA, PBS, the MSIA (Medical Software Industry Association) and the ADHA (Australian Digital Health Agency) - we participate across a number of e-Health Steering Committee groups involving Government Organisations around Medicines safety. Within the ANZ region, MIMS Australia and NZ has been publishing Medicines information since 1963. We have strengthened our position as the leading supplier of trusted, quality, independent medicine information for healthcare professionals, and are known for our high level of editorial integrity and independence. MIMS offers a range of digital products; from hand held devices to online portals and full integration into Primary and Acute Care clinical software applications. Our MIMS Drug Information System is the most advanced, and up-to-date information source, delivering critical information at the point of care. We are proud to liaise with and integrate our MIMS platform with over 80 leading Clinical System partners - reaching the widest audience of Healthcare Professionals across the ANZ region -> approx +500,000 active Clinical Users daily. We provide monthly updates via our extensive team of +200 Medical Editorial Staff.
At the most recent AGM held in October 2025, I was again humbled to be re-elected as National President. As President of the MSIA, my role is to assist and work closely with our CEO, Board and members to ensure we represent the interests of the Australian Medical Software Industry which develops, supplies information management products and digital health technology solutions to over 95% of all healthcare professionals, healthcare service providers and broader healthcare organisations across Australia. The role also requires working with and understanding counterparts across MedTech, HealthTech, BioTech and Digital Health industries. Incorporated over 20 years ago, MSIA is a well-established conduit between Government and Industry, with members being represented on a range of forums, working groups and committees, with the MSIA negotiating a range of important changes with Government and other Stakeholders. The MSIA has built a considerable profile with Federal and State Health Departments and is now acknowledged as the official 'voice' for the industry. In essence, the entire Australian healthcare system is reliant and dependent upon the HealthTech produced, developed, enhanced and enabled by all our members, to ensure efficiency and safety of dealing with patients on a daily basis.
The MSIA represents the interests of the Australian Medical software industry which develops, supplies information management products and services for healthcare practitioners, healthcare service providers and broader healthcare organisations across Australia. The MSIA is a passionate organisation whose ongoing goal is to enable a vibrant medical industry in Australia and promote the value of technology to improve health outcomes. The main functions of the association are to: - provide a collective and representative voice of the Members in discussions and negotiations with government, other associations and representative bodies, individuals and commercial companies. - provide a mechanism for other organisations and individuals to communicate effectively with the Members. - provide a means by which intelligence and information can be distributed to the Members. - provide a forum for effective cooperation by the Members in areas which will be mutually beneficial.
In January 2014, I was responsible for the acquisition of eHealthwise (and its THELMA Health Exchange SaaS Platform) from WiseTech Global (ASX Code: WTC) to SMS Co Limited. In August 2016, I then sold eHealthWise from 100% SMS Co Ltd into MIMS Australia (which is part of the MIMS Group and owned by SMS Co Ltd). I continue with full responsibility for the eHealthWise Australian/NZ product platform and business, while driving the platform / technology into 17 x MIMS ASEAN markets. I currently serve as its CEO and Executive Board Director, working with; the MIMS Group CEO, our Executive Team in Singapore and our International HQ located in Tokyo. We have won the prestigious NSW State Government ICT iAwards for the Health Sector in Australia. During 2015/16, our 'THELMA' platform processed in excess of AUD$700 Million of electronically billed claims / eCommerce through our secure e-claiming Switching Platform. By the end of 2022, we transacted in excess of AUD1$Billion p.a. of e-claims / eCommerce value. Our cloud based THELMA platform (Transactional Health Exchange Linking Multiple Applications) has been processing B2B e-health billing and claims in Australia for +10 years and was certified with Medicare Australia in 2006. We specialise across various e-health transactions for HealthCare Providers. Our SaaS e-Billing & e-Claiming Solution integrates to most legacy Vendor systems via Web Services, or can also provide a standalone, secure web based solution. We have strong relationships with Customers and via our Vendor System Partners across the Australian healthcare industry, providing services to Public hospitals in NSW, QLD & VIC, Day Clinics and Private Hospitals throughout Australia. Our parent company, MIMS Group, is located across 17 Countries in Asia - aside from domestic business, my Executive role is to also drive opportunities for our Health Exchange e-Claiming platform with strategic CIS/HIS/PMS System Vendor partners across these Asian markets.
For 6 years, I was an Executive Board Director of RIS Group Limited (RIS), a publicly listed company on the New Zealand Stock Exchange (NZX). My responsibilities included; liaising with the NZX, Shareholders, Auditors, various Board Members, Advisors and relevant Compliance officers whilst working with fellow Directors / Management regarding strategic business opportunities. The Company was a small cap stock, peaking at approx. AUD$90million market capitalisation in 2009. Post the divestment of its Australian Payments IT subsidiary, the Board reached an agreement with a commercial party in Q4 of 2015, announcing at a Special Meeting of Shareholders, there would be a reverse listing with the Chow Brothers ("CGML - www.cgml.co.nz" - a NZD$200million successful and privately owned commercial property group in NZ). This made way for a new Board, and a new company direction with specialist Commercial Property Management personnel to take RIS Group into the commercial property industry. In March 2016, RIS Group Limited ("RIS") changed its name and NZX code to Chow Group Limited ("CGL"). CGL was then delisted from the NZX as Management decided to revert back to a Privately owned Company in July 2018.